For Providers

Bridgeway provides medically supervised IV ketamine therapy for appropriately screened patients as an adjunct to ongoing mental-health care. We work exclusively with patients who are currently engaged with at least one licensed mental health professional, including psychologists, social workers, or mental health counselors. This collaborative model ensures that each patient benefits from comprehensive and coordinated support.

At Bridgeway, intravenous ketamine is regarded as a valuable adjunct within an integrated mental health framework rather than a replacement for ongoing therapy or psychiatric care. Our primary objective is to complement existing treatment strategies to optimize patient outcomes.